Anchorage Capital Group, L.L.C.

In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Anchorage Capital Group, L.L.C. reported 5 stock positions worth $272.5 million. Its top holding was Sentinelone Class A (S) at 40.2% of the portfolio, followed by Frontier Communications Pare (FYBR, 31.1%) and Roivant Sciences (ROIV, 21.0%). Compared with Q3 2024, it reduced 1. The biggest sale was Frontier Communications Pare (FYBR, shares −52%).

Most Recent 13F
Q2 2026
Location
NEW YORK, NY
CIK
0001300714
Portfolio Value
$272.5M (Q4 2024)
SEC Filing
0000905148-25-000656 ↗ filed Feb 14, 2025

Holdings Value

0$100.0M$200.0M$300.0M$400.0M$500.0M Q1 2024: $377.5M Q1 2024 Q2 2024: $316.7M Q2 2024 Q3 2024: $374.8M Q3 2024 Q4 2024: $272.5M $272.5M Q4 2024 Q1 2025: $239.9M Q1 2025 Q2 2025: $258.7M Q2 2025 Q3 2025: $117.4M Q3 2025 Q4 2025: $88.6M Q4 2025 Q1 2026: $436.3M Q1 2026 Q2 2026: $450.5M Q2 2026

Holdings 5 stocks · $272.5M
S Sentinelone Inc. Class A 40.22% 4,937,053 $109.6M No change
FYBR Frontier Communications Pare 31.12% 2,443,742 $84.8M Reduce -52.3%
ROIV Roivant Sciences Ltd. 20.98% 4,832,642 $57.2M No change
DNA Ginkgo Bioworks Holdings Inc. 6.29% 1,746,363 $17.1M No change
AMBP Ardagh Metal Packaging SA 1.38% 1,250,000 $3.8M No change
Other holdings (2): bonds, preferreds, convertibles and warrants · $11.7M (not counted above)
SecurityClassShares / PrincipalValueChange
THE REALREAL INC (REAL 1 03/01/28) NOTE 1.000% 3/0 · principal 15,097,000$11.7MNo change
AMPWF Ardagh Metal Packaging -CW26 *W EXP 08/04/202 1,245,385$37KNo change

Total filed on the 13F, all lines: $284.2M.

Portfolio Sells Q3 2024 → Q4 2024
FYBR Frontier Communications Pare Reduce -52.3% 31.12% −17.44

Portfolio Buys Q3 2024 → Q4 2024
None this quarter.

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q2 2026 3$450.5MEQPT, S, DNA
Q1 2026 3$436.3MEQPT, S, DNA
Q4 2025 2$88.6MS, DNA
Q3 2025 3$117.4MS, DNA, AMBP
Q2 2025 5$258.7MS, FYBR, ROIV, DNA, AMBP
Q1 2025 5$239.9MS, FYBR, ROIV, DNA, AMBP
Q4 2024 5$272.5MS, FYBR, ROIV, DNA, AMBP
Q3 2024 5$374.8MFYBR, S, ROIV, DNA, AMBP
Q2 2024 5$316.7MFYBR, S, ROIV, DNA, AMBP
Q1 2024 6$377.5MFYBR, S, DNA, ROIV, AMBP